Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.3 USD | +0.30% | -0.56% | -3.43% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.52B | |
+1.43% | 50.06B | |
+11.60% | 45.67B | |
+3.40% | 41B | |
+3.03% | 26.73B | |
+3.21% | 26.47B | |
+15.23% | 25.05B | |
-1.76% | 24.56B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating